Development of a Transcreener kinase assay for protein kinase A and demonstration of concordance of data with a filter-binding assay format
- PMID: 17409274
- DOI: 10.1177/1087057107300221
Development of a Transcreener kinase assay for protein kinase A and demonstration of concordance of data with a filter-binding assay format
Abstract
A Transcreener kinase fluorescence polarization (FP) assay has been developed for the serine/threonine kinase protein kinase A (PKA). The PKA Transcreener kinase assay is an homogenous, competitive antibody-based FP assay that uses Far Red Alexa Fluor 633-labeled adenosine 5' disphosphate (ADP) tracer and mouse monoclonal anti-ADP antibody. The Transcreener PKA assay was validated with both known PKA inhibitors and library compounds. The Transcreener PKA assay is resistant to low-wavelength (or common) fluorescent interference from small-molecule library compounds and generates IC50 results comparable with current radioactive filter-binding assay.
Similar articles
-
Development of a microplate-based, electrophoretic fluorescent protein kinase a assay: comparison with filter-binding and fluorescence polarization assay formats.J Biomol Screen. 2005 Jun;10(4):329-38. doi: 10.1177/1087057104272909. J Biomol Screen. 2005. PMID: 15964934
-
Fluorescence polarization competition immunoassay for tyrosine kinases.Methods. 2000 Sep;22(1):61-70. doi: 10.1006/meth.2000.1037. Methods. 2000. PMID: 11020319
-
Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody.Anal Biochem. 2001 Dec 1;299(1):45-53. doi: 10.1006/abio.2001.5412. Anal Biochem. 2001. PMID: 11726183
-
A fluorescence lifetime based binding assay to characterize kinase inhibitors.J Biomol Screen. 2007 Sep;12(6):828-41. doi: 10.1177/1087057107304480. Epub 2007 Jul 20. J Biomol Screen. 2007. PMID: 17644772
-
Diagnosis of militarily relevant diseases using oral fluid and saliva antibodies: fluorescence polarization immunoassay.Mil Med. 2003 Nov;168(11):915-21. Mil Med. 2003. PMID: 14680048 Review.
Cited by
-
Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes.Assay Drug Dev Technol. 2010 Jun;8(3):344-55. doi: 10.1089/adt.2009.0254. Assay Drug Dev Technol. 2010. PMID: 20158441 Free PMC article.
-
Massively multiplex chemical transcriptomics at single-cell resolution.Science. 2020 Jan 3;367(6473):45-51. doi: 10.1126/science.aax6234. Epub 2019 Dec 5. Science. 2020. PMID: 31806696 Free PMC article.
-
Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model.Invest New Drugs. 2012 Jun;30(3):936-49. doi: 10.1007/s10637-011-9640-6. Epub 2011 Mar 1. Invest New Drugs. 2012. PMID: 21360050
-
Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties.Pharmaceutics. 2022 Sep 15;14(9):1954. doi: 10.3390/pharmaceutics14091954. Pharmaceutics. 2022. PMID: 36145702 Free PMC article.
-
Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.Assay Drug Dev Technol. 2009 Feb;7(1):56-67. doi: 10.1089/adt.2008.175. Assay Drug Dev Technol. 2009. PMID: 19187009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources